Skip to main content
PLOS One logoLink to PLOS One
. 2024 Mar 29;19(3):e0293858. doi: 10.1371/journal.pone.0293858

Bicyclomycin generates ROS and blocks cell division in Escherichia coli

Anand Prakash 1,*, Dipak Dutta 1
Editor: Samiullah Khan2
PMCID: PMC10980228  PMID: 38551933

Abstract

The role of reactive oxygen species (ROS) in the killing exerted by antibiotics on bacteria is debated. Evidence attributes part of toxicity of many antibiotics to their ability to generate ROS by interfering with cellular metabolism, but some studies dismiss the role of ROS. Bicyclomycin (BCM) is a broad-spectrum antibiotic that is the only known compound to inhibit E. coli transcription terminator factor Rho with no known other cellular targets. In the present study, we addressed this question by checking whether the induction of oxidative stress could explain the increased sensitivity to Bicyclomycin in the hns deleted strain even in Δkil background in E. coli. BCM evoked the generation of ROS in E. coli cells. BCM is known to cause the cell filamentation phenotype in E. coli. Performing fluorescence microscopic analysis, we show that bicyclomycin-dependent cell filamentation is associated with SOS response. RecA-GFP filaments were found to colocalize with the damaged DNA sites in the cell. Further analysis revealed that the genomic DNA was partitioned but the cell septum formation was severely affected under BCM treatment. Furthermore, we observed biofilm formation by E. coli after BCM treatment. We hypothesize that ROS production after BCM treatment could lead to cell filamentation in bacteria. A better understanding of the mode of toxicity of BCM will help us design better antibiotic treatment regimes for clinical practices, including combinatorial drug therapies. The cell filamentation phenotype observed after BCM treatment makes this antibiotic a promising drug for phage-antibiotic synergy (PAS) therapy.

Introduction

Many antibiotics are known to employ ROS as a means of their lethality against bacteria, and a common ROS-dependent killing mechanism employed by antibiotics has been proposed [14], However, some researchers have negated the role of ROS in the antibacterial properties of antibiotics [5, 6]. To add to our knowledge of the involvement of ROS in antibiotic-mediated killing of pathogens, we investigated whether an inhibitor of bacterial transcription terminator Rho, bicyclomycin (BCM), causes oxidative stress in Escherichia coli cells. BCM (also known as Bicozamycin) is an antibiotic obtained from several Streptomyces species (S. cinnamoneus, S. aizunensis and S. griseoflavus) [7, 8]. It displays toxicity against numerous gram-negative bacteria, viz. E. coli, Salmonella, Enterobacter, Shigella, Neisseria, etc. [9]. BCM has been used to treat traveler’s diarrhea [10], as well as used as a veterinary medicine to treat fish, calves, and pigs in veterinary medicine [1114].

BCM acts by inhibiting the transcription termination factor Rho [15], an essential protein in most Gram-negative bacteria [12, 16]. Two modes of BCM toxicity have been proposed; one is resulting from the inhibition of Rho function in E. coli, the activation of the kil gene product, and another by the double-stranded breaks (DSBs). The kil gene is carried by Rac prophage and codes for an inhibitor of cell division gene ftsZ [1719]. kil is preceded by a rho-terminator; thus, the transcriptional suppression of kil expression by Rho is released by BCM [20]. Screening of single-gene knockout mutants revealed that the hns deleted strain is sensitive to BCM even in Δkil background, suggesting that BCM toxicity has a mechanism other than kil gene mediated [21]. DSBs are generated due to increased collision of replisome with the transcription elongation complex (TEC) due to pervasive transcription after inhibition of Rho function [16, 22]. By checking intracellular ROS levels using dihydroethidium (DHE) and 2ˊ,7ˊ-dichlorodihydrofluorescein diacetate (H2DCFDA) probes and the promoter activity of soxS, ahpC, katG, and oxyR after BCM treatment, we probed whether BCM treatment could lead to oxidative stress in E. coli cells. ROS production inside the cell may result in a change in cell morphology. Cell elongation is a result of the SOS response [23]. DNA damage, the SOS response, and cell filamentation are interlinked. Mutants for the protease encoding gene lon were found to form filaments and were hypersensitive to ultraviolet radiation [24]. lon encodes for a protease that acts on many proteins, including the cell division regulator sulA [25]. DNA replication is halted for repair, and cell division is impaired when DNA damage occurs. This is why cells are quite elongated when there is damage to DNA [26]. We checked the morphology of E. coli in response to BCM using the lipophilic dye FM 4–64, which selectively stains the cell membrane.

Microorganisms produce biofilms in response to oxidative challenges in the environment. When subjected to oxidative stress Mycobacterium avium forms a biofilm [27]. Biofilm drives genetic diversity in response to oxidative stress [28]. We checked biofilm formation by E. coli after BCM treatment. Biofilm formation is dependent upon quorum sensing [2830]. Quorum sensing in E. coli is mediated by autoinducer-2 (AI-2) [31]. BCM treatment also led to the expression of rdar (red, dry, and rough) colonies. The rdar morphotype is displayed by Enterobacteriaceae. It is a multicellular behavior of microorganisms resulting from the expression of curli fimbriae and the adhesive components of extracellular matrix [32].

Results

BCM treatment leads to arrested cell growth and ROS production in E. coli cells

Growth curve experiments were performed to check the effect of BCM on the growth of wild-type BW25113 cells. Cells showed impaired growth profiles when grown in the presence of BCM. The minimum inhibitory concentration (MIC) of BCM for the WT BW25113 strain is 37 μg/ml [33]. At a concentration of 25 μg/ml (0.7X MIC) of BCM, the wild-type cell showed an extended lag phase, and at 50 μg/ml (1.4X MIC) BCM concentration, plateau-type growth was observed without any log phase (Fig 1A). We suspected that apart from inhibiting the Rho function, the reduced growth may be due to increased ROS levels in the cells after BCM treatment. ROS levels in cells grown in the presence of BCM were probed using DHE and H2DCFDA dyes. Many antibiotics are known to generate superoxide radicals by interfering with cellular metabolism in bacterial cells [1]. In our study, approximately 3-fold higher levels of superoxide were detected by DHE after antibiotic BCM treatment (Fig 1B). The soxS gene is induced when the intracellular levels of superoxide increase in the cells [34]. We found an increased promoter activity of soxS after BCM treatment. In addition, the soxS promoter activity was decreased when superoxide quencher tiron (TI) was added to the media (Fig 1C). In agreement with these findings, 1.8-fold increases in the SodA level were found after BCM treatment (Fig 1D and 1E).

Fig 1. WT cells exhibit retarded growth and higher ROS levels after BCM treatment.

Fig 1

A. WT cells show a retarded growth phenotype in the presence of BCM, Data are means ± SD (n = 3). B. Higher levels of superoxide were detected after BCM treatment with DHE in WT. *, P < 0.05. C. Bar graph showing higher levels of promoter activity of soxS after BCM treatment. **, P < 0.01. D. & E. Western blot showing1.8-fold increase in the expression level of SodA (24 Kd) after BCM (50 μg/ml) treatment using anti-SodA antibody. Ponceau staining was performed to show equal loading of lysate in wells. Data are means ± SD (n = 2). F. H2DCFDA dye fluorescence increased after BCM treatment in WT. Error bars in the panels are mean ± SD from the three independent experiments. **, P < 0.01. *, P < 0.05, paired t-test.

Furthermore, the global intracellular ROS species levels were probed using H2DCFDA dye, which is pretty responsive to almost all major ROS species generated inside the cell [35]. Approximately 7-fold increases in intracellular ROS levels were detected by H2DCFDA dye after BCM treatment (Fig 1F). The promoter activities of the genes involved in the mitigation of ROS inside the cell were checked after BCM treatment using GFP-reporter constructs. We observed an increase in the promoter activity of soxS, katG, ahpC, and oxyR genes under BCM treatment (Fig 2A). The increase in the promoter activity of these genes was nullified when the hydroxyl free radical quencher thiourea was added along with BCM in the media (Fig 2A). These results suggest that exposure to BCM also leads to the generation of highly deleterious hydroxyl radicals in E. coli cells. Hydroxyl free radicals are most potent in damaging DNA. After quantifying the intracellular ROS production after BC treatment, we checked whether ROS generated by BCM is directly implicated in the retarded growth of E. coli cells. We examined the effect of BCM on the growth of ΔsodA ΔkatG ΔahpC triple mutant. In the absence of BCM, the triple mutant and WT grew almost identically; however, the triple mutant strain displayed increased sensitivity compared to the WT in the presence of BCM (S1 Fig in S1 File), establishing that ROS generation after BCM treatment resulted in the retarded growth profile of E. coli cells in the presence of the antibiotic.

Fig 2. BCM treatment leads to increase in promoter activity of ROS responsive genes and induction of SOS response.

Fig 2

A. Around 2-fold increase in the promoter activity of soxS, katG, ahpC, and oxyR genes was found after BCM treatment. **, P < 0.01. *, P < 0.05. B. Bar graph showing increase in RecA-GFP fluorescence after BCM treatment, supplementation of thiourea resulted in a decrease in RecA-GFP fluorescence. ***, P < 0.001.

BCM treatment leads to the induction of SOS response and cell filamentation

BCM is known to cause the cell filamentation phenotype in E. coli [36]. In addition, BCM treatment leads to replication transcription conflicts and DNA damage [16, 22]. We checked cell septum formation, genomic DNA organization, and SOS response after BCM treatment using fluorescence microscopy. We grew WT E. coli containing recA-gfp reporter fused in the chromosome and treated with BCM. Lipophilic FM 4–64 dye was used to stain the membrane and DAPI for genomic material. Consistent with previous reports, E. coli cells exhibited filamentous phenotypes after treatment with BCM. Cell length increased approximately 10-fold after BCM (25 μg/ml) addition. Cell filamentation was almost abrogated when tiron was added to BCM-treated cells (Fig 3A and 3B). Inhibition of cell filament formation by tiron in the presence of BCM was in agreement with the increase in the fluorescence intensity of DHE and the increase in the promoter activity of soxS in the BCM-treated cells (Fig 1B and 1C). This suggests that BCM treatment leads to the superoxide formation in the cells. The effect of thiourea, another ROS quencher, was examined on cell filamentation by BCM. Thiourea treatment decreased the length of filamented cells treated with BCM (50 μg/ml) (Fig 4A and 4B). All these observations suggest that along with superoxide, hydroxyl radicals are also formed in BCM-treated cells, which lead to cell filamentation. We also checked whether ROS scavengers tiron and thiourea had any effect on the growth of E. coli cells. WT cells grew almost identically in the presence and absence of thiourea, and in the presence of tiron, WT cells displayed a very minor growth defect (S2 Fig in S1 File).

Fig 3. Cells were highly filamented after treatment with BCM.

Fig 3

A. Phase-contrast microscopy image showing cell filamentation after BCM (25 μg/ml) treatment. Cell length increased approximately 10-fold in the presence of BCM. B. When tiron was added along with BCM, cell filamentation decreased. The calculated mean ± SD values from 30 cells were plotted. ***, P < 0.001.

Fig 4. BCM treatment resulted in inhibition of septum formation.

Fig 4

A., B. Cells became highly filamented after the addition of BCM (50 μg/ml), and after supplementation with thiourea, cell filamentation decreased. ***, P < 0.001. **, P < 0.01. The cell in the inset is zoomed to show the inhibition of septa formation and colocalization of DAPI and RecA-GFP fluorescence signals in the lower panels. C. Image showing partitioning of the genetic material stained by both DAPI and FM 4–64 (left panel) and abrogation of septum formation in the membrane stained by FM 4–64 dye (right panel) in the presence of BCM. D. RecA-GFP foci colocalized with damaged DNA stained by DAPI in presence of BCM.

Incomplete septum formation was observed in the presence of BCM by the lipophilic dye FM 4–64 dye, which stains the membrane of bacteria (Fig 4C). When cells were stained with both DAPI and FM 4–64 after BCM treatment, duplication of genetic material was evident with incomplete septum formation in the cell filaments (Fig 4C). Similarly, the modulator of FtsZ cytoskeletal protein EzrA coding gene was 13 fold upregulated, and ftsB, ftsX, and envC genes involved in cell division were also moderately upregulated in microarray after BCM treatment (S2 Table in S1 File) [20]. The addition of BCM resulted in an increase of RecA-GFP fluorescence, indicating the induction of SOS response after BCM treatment (Fig 2B). RecA-GFP filaments were found to colocalize with damaged DNA sites in the cell. The co-localization of RecA-GFP foci with DAPI (Fig 4D) suggests DSBs, which is consistent with previous findings that antibiotics cause DSBs. In agreement with these results, the SOS-responsive genes, such as dinB, umuD, sosD, uvrD, and ruvC were upregulated to 8, 6, 10, 3, and 1.5-fold, respectively, after BCM treatment in the microarray data (S1 Table in S1 File) [20]. These observations suggest that ROS produced after BCM treatment led to the induction of SOS response in E. coli, due to which cell division was halted, and because of the impairment of cell division, cells become highly filamented.

BCM treatment leads to biofilm formation

Microorganisms form a biofilm to combat environmental challenges, including oxidative stress [16, 27, 28]. Thus, after the BCM challenge, biofilm formation was checked on a microtiter plate by staining with crystal violet dye. Biofilm formation was observed after the addition of BCM. Biofilm formation increased with increasing concentration of BCM (Fig 5A and 5B). Biofilm formation is dependent on quorum sensing [29, 30]. Quorum sensing in E. coli is mediated by autoinducer-2 (AI-2) [31]. luxS synthesizes autoinducer-2 (AI-2) [37, 38]. No biofilm was formed in the ΔluxS strain (Fig 5A and 5B). Biofilm formation was quantified by measuring the absorbance of the crystal violet dye at 550 nm recovered from the biofilm. The absorbance of crystal violet increased with increasing concentrations of BCM, suggesting that with a higher amount of BCM, biofilm formation by WT E. coli cells also increased (Fig 5B). BCM treatment also led to expression of rdar (red, dry, and rough) morphotype in E. coli colony (Fig 5C). In accordance with these results, the luxS and other genes involved in the biosynthesis of adhesive appendages curli (csgA-G) and fimbriae (sfmA, sfmH, ydeT, yfcV, yadN, elfA) were upregulated after BCM treatment in microarray in E. coli (S3 Table in S1 File) [20]. These results suggest that BCM treatment leads to biofilm formation in E. coli.

Fig 5. E. coli form a biofilm in response to BCM.

Fig 5

A. Image showing the formation of biofilm with increasing concentrations of BCM in WT E. coli, but no biofilm formed in ΔluxS strain. B. Scatter plot showing the absorbance of crystal violet recovered from biofilm formed in different concentrations of BCM from WT and ΔluxS strain. C. Expression of the rdar morphotype was visualized on LB without salt plates supplemented with 40 μg/ml Congo Red and 20 μg/ ml Coomassie Brilliant Blue G-250 after addition of BCM.

Discussion

With ever-increasing antibacterial resistance, novel strategies and innovations are needed to tackle emerging antibiotic-tolerant pathogens. For this, a detailed understanding of the mode of action of antibiotics is crucial. A better understanding of the toxic effects of antibiotics will help us design better strategies, such as synergic drug therapy and phage-antibiotic synergy (PAS). Apart from potentiating the killing of bacteria by binding to their primary targets in cells, ROS generated by perturbation of cellular pathways by antibiotics has been uncloaked as an effective arsenal against bacteria. Norfloxacin caused superoxide-mediated oxidation of the iron-sulfur cluster and subsequent generation of hydroxyl radical breakdown through the Fenton reaction in E. coli [4]. Kanamycin, ampicillin, norfloxacin, and vancomycin were shown to induce hydroxyl radical formation and cell lysis in the case of ampicillin in E. coli cells [1]. Some studies that disapprove of the role of ROS in antibiotic-mediated killing of bacteria were fairly evaluated by considering the experimental setup and some technical aspects of the studies [3, 5, 6, 39]. BCM belongs to the 2,5dikeopiperazinies class of peptide antibiotics. Rarely observed for any antibiotic, BCM biosynthetic gene clusters are highly conserved and widespread in both Gram-negative and Gram-positive bacteria. After the discovery of BCM from Streptomyces species, BCM gene clusters were subsequently identified in hundreds of Pseusomonas aeruginosa isolates from different geographical regions, and putative BCM gene clusters have been found in seven genera of Actinobacteria and Proteobacteria (Alphaproteobacteria, Betaproteobacteria, and Gamaproteobacteria) [7, 40]. BCM treats diarrhea in humans, calves and pigs [10, 13, 14]. It is also economically crucial for aquaculture as it is used in the treatment of pseudotuberculosis in fish [11]. BCM is a single natural product that inhibits Rho function, along with its tested safety in mammals and its toxic effects against clinically critical pathogens like Klebsiella pneumoniae and Acinetobacter baumannii, making it an exceptionally promising antimicrobial compound [12, 33]. The hope is further enhanced by the fact that when BCM was combined with bacteriostatic concentrations of protein synthesis targeting antibiotics, it displayed a high bactericidal synergy [33]. Further, a close inspection of the structure of BCM revealed that its activity can be increased by alterations in its exomethylene group [41, 42].

Although cell filamentation after BCM treatment was reported by its discoverers as early as 1979, the reason behind this was obscure. The toxic effect of BCM is attributed to the inhibition of bacterial transcription terminator factor Rho [16, 22]. Here, we report that free radical generation is an important means of BCM toxicity, apart from the inhibition of Rho function. We found an increased ROS levels by DHE and H2DCFDA dye in E. coli cells after treatment with BCM. The promoter activity of soxS, katG, ahpC, and oxyR increased two-fold after BCM treatment. SodA levels increased 1.8-fold inside the cells after BCM treatment. Cell filamentation decreased after adding the superoxide and hydroxyl radical quenchers tiron and thiourea, respectively. These results suggest that cell filamentation observed after BCM treatment is the result of ROS production in response to BCM. Cell filaments are formed as a result of the SOS response when DNA is damaged due to environmental factors such as UV radiation or ROS [24, 26]. The cell filamentation effect of BCM on bacterial cells makes it a promising antibiotic for use in PAS in clinical practice. A previous study has demonstrated that filamentous cells are more prone to phages because of their increased surface area [43]. Overall, previous findings and our results suggest that BCM toxicity results from Rho inhibition as well as the generation of free radicals (Fig 6). The collisions between the transcription elongation complex and replisome resulting from Rho inhibition and hydroxyl radical production evoked by BCM converge to generate DSBs. The DSBs resulted in the activation of the SOS response pathway and subsequently in cell filamentation due to inhibition of cell division. Although we did not check the envelope stress after BCM treatment, it may be implicated in the generation of ROS after BCM treatment. The unregulated expression of proteins due to Rho inhibition may perturb the tricarboxylic acid cycle (TCA) cycle. Earlier, the expression of misfolded proteins has been shown to cause ROS production through the induction of envelope stress [2]. kil expression after Rho inhibition resulted in cell filamentation by inhibiting FtsZ function. Biofilm formation was also observed in response to BCM-induced oxidative stress. Biofilm formation was inhibited when luxS was deleted. Thus, biofilm formation due to BCM is luxS-dependent in E. coli. In E. coli, the effect of AI-2 is delivered through SdiA, which is homologous to LuxR-type transcriptional activators. AI-2-activated SdiA has been shown to regulate cell division in E. coli in a ftsQAZ-dependent manner [44]. Two modes of free radical formation by antibiotics have been deciphered. Quinolones, aminoglycosides, and β-lactams perturbed the TCA cycle, leading to low NADH levels [1]. This stimulated damage of the iron-sulfur cluster, leading to the leaching of ferrous iron, which participated in the Fenton reaction, forming hydroxyl radicals, subsequently leading to cell death. Ribosome targeting andaminoglycoside-induced ROS production was shown to be linked with misfolded proteins in membrane and periplasmic space via envelope stress response two-component system [2]. ROS production after BCM treatment may result from metabolic stress due to enhanced expression of proteins after inhibiting Rho function. Further studies are needed to unmask the events of BCM-mediated ROS production.

Fig 6. H. Model for the BCM mode of action.

Fig 6

BCM evokes superoxide formation through the TCA cycle or envelope stress response pathway, which is converted to hydroxy radicals through the Fenton reaction. Hydroxyl radicals and the collision between TEC and replisome cause DSBs in the E. coli genome. At the DSBs, RecA protein is recruited and SOS response is induced. Because of the SOS response, cell division is halted and cells become filamented. kil expression after Rho inhibition inhibits FtsZ function, leading to cell filamentation.

Materials and methods

Bacterial strains and plasmids

The wild-type BW25113 (WT) strain of E. coli is from the KEIO collection [45]. recA-gfp was freshly transduced into the WT genome by P1 phage transduction to obtain the BW25113::recA-gfp strain [46]. The reporter plasmids pUA66_soxS, pUA66_ahpC and pUA66_katG were provided by Dr. Csaba Pal, Biological Research Centre, Hungarian Academy of Sciences [47].

Chemicals

Dihydroethidium (DHE) and 2ˊ, 7’-dichloro-dihydrofluorescein diacetate (H2DCFDA), FM 4–64, Thiourea, Crystal violet, Congo red, 4,5-Dihydroxy-1, - 3-benzenedisulfonic acid (Tiron) and Bicyclomycin were purchased from Sigma.

Growth conditions

The primary culture was grown overnight under shaking conditions at 37°C. The overnight grown primary culture of WT cells was inoculated into fresh LB broth at 100-fold dilution. The secondary cultures were grown for 1.5 h at 37°C till the O.D.600 reached approximately 0.3. BCM (25 μg/ml or 50 μg/ml) was added at this point and incubated for 3 h at 37°C. The bacterial pellets were collected, and different assays were performed.

Growth curve analyses

Saturated overnight culture of WT E. coli cells was diluted 100-fold in 1 ml of LB broth and grown in the presence and absence of BCM (25μg/ml or 50 μg/ml) in triplicate. The growth curves were followed for 16 h using an automated BioscreenC growth analyzer (Oy growth curves Ab Ltd.) with shaking at 37˚C. The mean of the three OD at 600 nm were plotted against time to obtain the growth profile of WT cells in the presence of BCM.

Checking ROS level and induction of SOS response by flow cytometry

The relative ROS level in WT BW25113 cells was probed using DHE and H2DCFDA dye. DHE is sensitive to superoxide, and H2DCFDA is sensitive to hydroden peroxide and hydroxyl radicals, and some other ROS species. Cells were grown for 4 h in the presence and absence of BCM (25μg/ml or 50 μg/ml) and the pellet was washed with 1X PBS. One part of the washed pellet was stained by 2 μM DHE, the other by 10 μM H2DCFDA for one hour, the third was dissolved in 1X PBS. RecA-GFP fluorescence after BCM treatment was checked using a specific E. coli strain that harbors an SOS responsive BW25113::recA-gfp fusion in the genome. The data were acquired using FACS accuri (BD) with 0.1 million cells. FL1 filter was used for H2DCFDA and RecA-GFP, and FL2 for DHE. Mean fluorescence intensity (MFI) values obtained from three experiments were plotted after subtracting background fluorescence.

Checking promoter activity of ROS-responsive genes

GFP-mut2 containing reporter plasmids, pUA66_katG, pUA66_ahpC, pUA66_oxyR, and pUA66_soxS, were transformed into the BW25113 WT strain. The transformed cells were grown with or without supplementation of BCM at 37˚C in shaking. BCM (50μg/ml) was added from starting with or without thiourea (70 mM),and tiron (40μM). The data were acquired using FACS acuri (BD) at FL1 laser for 0.1 million cells. MFI values obtained from two experiments were plotted after subtracting background fluorescence.

Checking intracellular SodA levels after BCM treatment

WT E. coli culture was grown overnight, inoculated in LB medium at 1:100 dilution, and allowed to grow at 37°C for 1.5 h under shaking conditions. BCM was added and incubated for 3 h at 37°C. Cells were pelleted and lysed using B-PER Reagent (Thermo scientific) supplemented with 100 μg/ml lysozyme and 1 mM PMSF, followed by sonication. 35 μg of lysate was loaded on 10% SDS-PAGE after quantifying the protein concentration using Bradford assay kit (Bio-Rad). After transferring the bands to nitrocellulose membrane, Ponceau S staining was performed to check for equal loading of protein on SDS-PAGE. 5% skimmed milk was used for blocking to avoid nonspecific binding. The membrane was incubated with polyclonal rabbit primary antibodies raised against purified SodA protein. After washing 3 times with TBST, the membrane was incubated for 1 h with HRP-conjugated anti-rabbit secondary antibody. Immobilon Forte Western HRP substrate (Millipore) was used to develop the blot.

Visualization of filament formation by confocal microscopy

WT cells harboring recA-gfp were grown for 1.5 h with or without 50 μg/ml of BCM. 10 μM of Tiron and 70 mM of thiourea were added wherever required. Cell pellets were washed with 1X PBS. Additionally, cells were stained with DAPI and FM 4–64 for half an hour to visualize genetic material and cell membrane, respectively. After fixing the cells with 4% formaldehyde, slides were prepared using 10 μl of sample and examined using Nikon confocal microscope using 488 nm laser for GFP, 405 nm laser for DAPI and, 560 nm for FM 4–64. Image J. software was used to measure the relative cell lengths from around 30 cells.

Checking biofilm formation after BCM treatment

Biofilm formation after BCM treatment was checked in a microtiter plate. WT cells were seeded in 96 well plates in 200 μl LB medium with increasing concentration of BCM and incubated at 37˚C. After 24 h the media was decanted and washed with distilled water to remove any unattached cells. 125 μl of a 0.1% solution of crystal violet (CV) in water was used to stain the biofilm for 10 min. The plate was rinsed with water 3 times and blotted on tissue paper to remove any extra stain. The biofilm was photographed after drying the plate overnight. Next, biofilm formation with increasing concentration of BCM was quantified by estimating the amount of CV dye bound to it. CV was solubilized by adding 125 μl of 30% acetic acid to each well of the microtiter plate and kept for 10 min. The solubilized CV was transferred to a new 96-well plate. Absorbance was measured using BiotekPowerWave ™ XS plate Reader at 550 nm and plotted. To check the effect of BCM on colony morphology, LB without salt agar plates were prepared. Expression of the (red, dry, and rough) rdar morphotype was visualized on LB without salt plates supplemented with 40 μg/ml Congo Red and 20 μg/ ml Coomassie Brilliant Blue G-250.

Statistical analyses

Experiments were performed in triplicate. Data analyses and normalization were done using Microsoft Excel, and graphs were plotted using GraphPad Prism software. Cell length measurement and densitometry of western blots were done using imageJ software. P values were calculated from the paired t- test, and the values < 0.05 were considered significant. Data are plotted as means ± standaed deviation (SD).

Supporting information

S1 File

(DOCX)

pone.0293858.s001.docx (192.4KB, docx)
S2 File

(XLSX)

pone.0293858.s002.xlsx (13.6MB, xlsx)

Acknowledgments

AP was a senior research fellow, DBT. AP is thankful to Mr. Deepak Bhatt (CSIR-IMTECH) for helping in acquisition of confocal images.

Data Availability

All relevent data are within the manuscript and its supporting Information files.

Funding Statement

The authors didn’t get any specific funding for this work.

References

  • 1.Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130(5):797–810. doi: 10.1016/j.cell.2007.06.049 [DOI] [PubMed] [Google Scholar]
  • 2.Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death. Cell. 2008;135(4):679–90. doi: 10.1016/j.cell.2008.09.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Van Acker H, Gielis J, Acke M, Cools F, Cos P, Coenye T. The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria. Plos One. 2016;11(7). doi: 10.1371/journal.pone.0159837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol. 2007;3. doi: 10.1038/msb4100135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liu Y, Imlay JA. Cell death from antibiotics without the involvement of reactive oxygen species. Science. 2013;339(6124):1210–3. doi: 10.1126/science.1232751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science. 2013;339(6124):1213–6. doi: 10.1126/science.1232688 [DOI] [PubMed] [Google Scholar]
  • 7.Witwinowski J, Moutiez M, Coupet M, Correia I, Belin P, Ruzzini A, et al. Study of bicyclomycin biosynthesis in Streptomyces cinnamoneus by genetic and biochemical approaches. Sci Rep. 2019;9(1):20226. doi: 10.1038/s41598-019-56747-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Miyoshi T, Miyairi N, Aoki H, Kosaka M, Sakai H. Bicyclomycin, a new antibiotic. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo). 1972;25(10):569–75. doi: 10.7164/antibiotics.25.569 [DOI] [PubMed] [Google Scholar]
  • 9.Tanaka N, Iseki M, Miyoshi T, Aoki H, Imanaka H. Mechanism of action of bicyclomycin. J Antibiot (Tokyo). 1976;29(2):155–68. doi: 10.7164/antibiotics.29.155 [DOI] [PubMed] [Google Scholar]
  • 10.Harford PS, Murray BE, DuPont HL, Ericsson CD. Bacteriological studies of the enteric flora of patients treated with bicozamycin (CGP 3543/E) for acute nonparasitic diarrhea. Antimicrob Agents Chemother. 1983;23(4):630–3. doi: 10.1128/AAC.23.4.630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Godoy DT, Mian GF, Zanolo R, Yuhara TY, Faria FC, Figueiredo HCP. Patterns of resistance to florfenicol and bicyclomycin in Brazilian strains of motile aeromonads. Aquaculture. 2008;285(1–4):255–9. [Google Scholar]
  • 12.Kohn H, Widger W. The molecular basis for the mode of action of bicyclomycin. Curr Drug Targets Infect Disord. 2005;5(3):273–95. doi: 10.2174/1568005054880136 [DOI] [PubMed] [Google Scholar]
  • 13.Misawa N, Sueyoshi M, Uemura R, Kakemizu Y, Kawashima K, Nagatomo H, et al. Effect of bicozamycin on the eradication of Shiga toxin-producing Escherichia coli in calves. Microbiol Immunol. 2000;44(11):891–6. doi: 10.1111/j.1348-0421.2000.tb02580.x [DOI] [PubMed] [Google Scholar]
  • 14.Yoshimura H, Hamamoto S, Ishihara Y. Plasma concentrations and tissue residues of bicozamycin given orally to pigs. Vet Res Commun. 1995;19(3):215–20. doi: 10.1007/BF01839300 [DOI] [PubMed] [Google Scholar]
  • 15.Skordalakes E, Brogan AP, Park BS, Kohn H, Berger JM. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin. Structure. 2005;13(1):99–109. doi: 10.1016/j.str.2004.10.013 [DOI] [PubMed] [Google Scholar]
  • 16.Washburn RS, Gottesman ME. Transcription termination maintains chromosome integrity. Proc Natl Acad Sci U S A. 2011;108(2):792–7. doi: 10.1073/pnas.1009564108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hernández-Rocamora VM, Alfonso C, Margolin W, Zorrilla S, Rivas G. Evidence That Bacteriophage λ Kil Peptide Inhibits Bacterial Cell Division by Disrupting FtsZ Protofilaments and Sequestering Protein Subunits. J Biol Chem. 2015;290(33):20325–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Conter A, Bouché JP, Dassain M. Identification of a new inhibitor of essential division gene ftsZ as the kil gene of defective prophage Rac. J Bacteriol. 1996;178(17):5100–4. doi: 10.1128/jb.178.17.5100-5104.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Haeusser DP, Hoashi M, Weaver A, Brown N, Pan J, Sawitzke JA, et al. The Kil peptide of bacteriophage λ blocks Escherichia coli cytokinesis via ZipA-dependent inhibition of FtsZ assembly. PLoS Genet. 2014;10(3):e1004217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cardinale CJ, Washburn RS, Tadigotla VR, Brown LM, Gottesman ME, Nudler E. Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E-coli. Science. 2008;320(5878):935–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tran L, van Baarsel JA, Washburn RS, Gottesman ME, Miller JH. Single-gene deletion mutants of Escherichia coli with altered sensitivity to bicyclomycin, an inhibitor of transcription termination factor Rho. J Bacteriol. 2011;193(9):2229–35. doi: 10.1128/JB.01463-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dutta D, Shatalin K, Epshtein V, Gottesman ME, Nudler E. Linking RNA Polymerase Backtracking to Genome Instability in E. coli. Cell. 2011;146(4):533–43. doi: 10.1016/j.cell.2011.07.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Friedman N, Vardi S, Ronen M, Alon U, Stavans J. Precise temporal modulation in the response of the SOS DNA repair network in individual bacteria. Plos Biol. 2005;3(7):1261–8. doi: 10.1371/journal.pbio.0030238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Howard-Flanders P, Simson E, Theriot L. A locus that controls filament formation and sensitivity to radiation in Escherichia coli K-12. Genetics. 1964;49(2):237–46. doi: 10.1093/genetics/49.2.237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Schoemaker JM, Gayda RC, Markovitz A. Regulation of cell division in Escherichia coli: SOS induction and cellular location of the sulA protein, a key to lon-associated filamentation and death. J Bacteriol. 1984;158(2):551–61. doi: 10.1128/jb.158.2.551-561.1984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Imlay JA, Linn S. Mutagenesis and stress responses induced in Escherichia coli by hydrogen peroxide. J Bacteriol. 1987;169(7):2967–76. doi: 10.1128/jb.169.7.2967-2976.1987 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Geier H, Mostowy S, Cangelosi GA, Behr MA, Ford TE. Autoinducer-2 triggers the oxidative stress response in Mycobacterium avium, leading to biofilm formation. Appl Environ Microbiol. 2008;74(6):1798–804. doi: 10.1128/AEM.02066-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Boles BR, Singh PK. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A. 2008;105(34):12503–8. doi: 10.1073/pnas.0801499105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280(5361):295–8. doi: 10.1126/science.280.5361.295 [DOI] [PubMed] [Google Scholar]
  • 30.O’Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. P Natl Acad Sci USA. 2013;110(44):17981–6. doi: 10.1073/pnas.1316981110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li J, Attila C, Wang L, Wood TK, Valdes JJ, Bentley WE. Quorum sensing in Escherichia coli is signaled by AI-2/LsrR: effects on small RNA and biofilm architecture. J Bacteriol. 2007;189(16):6011–20. doi: 10.1128/JB.00014-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Römling U. Characterization of the rdar morphotype, a multicellular behaviour in Enterobacteriaceae. Cell Mol Life Sci. 2005;62(11):1234–46. doi: 10.1007/s00018-005-4557-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Malik M, Li L, Zhao X, Kerns RJ, Berger JM, Drlica K. Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics. J Antimicrob Chemother. 2014;69(12):3227–35. doi: 10.1093/jac/dku285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wu J, Weiss B. Two divergently transcribed genes, soxR and soxS, control a superoxide response regulon of Escherichia coli. J Bacteriol. 1991;173(9):2864–71. doi: 10.1128/jb.173.9.2864-2871.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Oparka M, Walczak J, Malinska D, van Oppen L, Szczepanowska J, Koopman WJH, et al. Quantifying ROS levels using CM-H(2)DCFDA and HyPer. Methods. 2016;109:3–11. doi: 10.1016/j.ymeth.2016.06.008 [DOI] [PubMed] [Google Scholar]
  • 36.Someya A, Tanaka K, Tanaka N. Morphological changes of Escherichia coli induced by bicyclomycin. Antimicrob Agents Chemother. 1979;16(1):87–91. doi: 10.1128/AAC.16.1.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schauder S, Shokat K, Surette MG, Bassler BL. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol. 2001;41(2):463–76. doi: 10.1046/j.1365-2958.2001.02532.x [DOI] [PubMed] [Google Scholar]
  • 38.Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A. 1999;96(4):1639–44. doi: 10.1073/pnas.96.4.1639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Van Acker H, Coenye T. The Role of Reactive Oxygen Species in Antibiotic-Mediated Killing of Bacteria. Trends Microbiol. 2017;25(6):456–66. doi: 10.1016/j.tim.2016.12.008 [DOI] [PubMed] [Google Scholar]
  • 40.Vior NM, Lacret R, Chandra G, Dorai-Raj S, Trick M, Truman AW. Discovery and Biosynthesis of the Antibiotic Bicyclomycin in Distantly Related Bacterial Classes. Appl Environ Microbiol. 2018;84(9). doi: 10.1128/AEM.02828-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Brogan AP, Widger WR, Bensadek D, Riba-Garcia I, Gaskell SJ, Kohn H. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry. J Am Chem Soc. 2005;127(8):2741–51. doi: 10.1021/ja046441q [DOI] [PubMed] [Google Scholar]
  • 42.Park BS, Widger W, Kohn H. Fluorine-substituted dihydrobicyclomycins: synthesis and biochemical and biological properties. Bioorg Med Chem. 2006;14(1):41–61. doi: 10.1016/j.bmc.2005.07.075 [DOI] [PubMed] [Google Scholar]
  • 43.Bulssico J, Papukashvil II, Espinosa L, Gandon S, Ansaldi M. Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation. PLoS Pathog. 2023;19(9):e1011602. doi: 10.1371/journal.ppat.1011602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.DeLisa MP, Valdes JJ, Bentley WE. Mapping stress-induced changes in autoinducer AI-2 production in chemostat-cultivated Escherichia coli K-12. J Bacteriol. 2001;183(9):2918–28. doi: 10.1128/JB.183.9.2918-2928.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008. doi: 10.1038/msb4100050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kostrzynska M, Leung KT, Lee H, Trevors JT. Green fluorescent protein-based biosensor for detecting SOS-inducing activity of genotoxic compounds. J Microbiol Methods. 2002;48(1):43–51. doi: 10.1016/s0167-7012(01)00335-9 [DOI] [PubMed] [Google Scholar]
  • 47.Zaslaver A, Bren A, Ronen M, Itzkovitz S, Kikoin I, Shavit S, et al. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods. 2006;3(8):623–8. doi: 10.1038/nmeth895 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Samiullah Khan

28 Nov 2023

PONE-D-23-34381Bicyclomycin generates ROS and blocks cell division in Escherichia coliPLOS ONE

Dear Dr. Prakash,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: 

​Dear author,

Revise the whole manuscript carefully in light of both reviewer's comments and submit it again.

==============================

Please submit your revised manuscript by Jan 12 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Samiullah Khan, Ph. D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following: 

● The name of the colleague or the details of the professional service that edited your manuscript

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure: 

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

Dear author,

Revise the whole manuscript in light of both reviewer's comments and submit again.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Methods

- The “Statistical data analysis” section is missing.

Results

- Figure 1.A shows the effect of BCM on the growth of E. coli by measuring OD600 at concentrations of 25 and 50 µg/ml. This indicator reflects the bacteriostatic effect of BCM. However, in this study, the bactericidal effect of antibiotic is more important. It is therefore desirable, in this and other cases, to additionally measure the effect of BCM on the colony forming ability (CFU) of E. coli at concentrations of 25, 50 and 100 µg/ml.

- Figure 1.A shows the effects of 25 and 50 µg/ml BCM, Figure 1.B shows the effects of 50 and 100 µg/m, and Figure 1.C does not show BCM concentrations at all.

- In Supplementary (table 1-3), fluorescence values in the control (without antibiotic) should be indicated.

- In experiments with the addition of antioxidants, it should be taken into account that in the concentrations used can significantly inhibit the growth of bacteria. As is known, even a slight decrease in growth can increase the resistance of bacteria to the action of bactericidal antibiotics. As a result, separate experiments must be performed to determine the effect of antioxidants on both promoter expression and the growth and survival of bacteria treated with antioxidants alone.

- The authors write:

“…Here, we report that apart from the inhibition of Rho function, free radical generation is an important means of BCM toxicity…

…Overall, previous findings and our results suggest that BCM toxicity results from Rho inhibition as well as the generation of free radicals..”.

The authors established the generation of reactive oxygen species by BCM by several methods, but the question of whether these ROS concentrations can have a toxic effect remains open. The toxic effects of bactericidal antibiotics include effects such as reduced survival and lysis, whereas the authors showed only a bacteriostatic effect. The production of ROS in itself does not necessarily lead to a bactericidal effect. Bacteria have powerful antioxidant defenses to prevent the toxic effects of sufficiently high concentrations of ROS.

The study revealed a number of effects associated with the action of BCM, but in order to establish their connection with ROS, additional experiments are required, in particular using mutants in antioxidant systems.

Reviewer #2: Dear Editor,

This is an interesting work that deepens and provides new information on the molecular and mechanistic bases in relation to the antimicrobial activity of bicyclomycin. In this work, various experimental approaches are carried out that provide new information of interest. Knowledge of the metabolic response to antimicrobials beyond their interaction with their primary target is a current topic that will be useful for the design of new therapeutic strategies.

Below are various points and comments that I understand are necessary for a better presentation of this work.

Major points

It is necessary to clarify or justify the concentrations of BMC used. Although it is mentioned that concentrations of 25 and 50 μg/ml of BCM were used, it is important to indicate them in relation to the minimum inhibitory concentration (MIC) of this drug. I suspect that it is equivalent to 1/2x and 1x MIC but the CMI value should be specified clearly.

Results (L5): I disagree with this sentence: “We suspected that the reduced growth may be due to increased ROS levels in the cells after BCM treatment.” The main molecular mechanism of growth inhibition by BMC is already known (Rho inhibition). Please rewrite this sentence.

I have important doubts with the quality of the images provided, at least in the version that I have been able to view. Please improve the quality of the images, especially Figure 1D, 4D, 5A and 4C. Additionally, I think that Figure 1F could be incorporated into Figure 2.

An important aspect of the work is that it should be more clearly specified what type of reactive oxygen species are detected by the DHE and H2DCFDA probes. This should be described precisely in Methods. In relation to this, the Results statement "These results suggest that exposure to BCM also leads to the generation of highly deleterious hydroxyl radicals" is not clear. Why do we talk about "hydroxyl radicals" specifically if H2DCFDA is a generic ROS marker?

Please delete this sentence from Discussion; “Although, we did not check the envelope stress after BCM treatment, it may be implicated in the generation of ROS after BCM treatment.” It is excessively speculative.

Methods: In relation to this sentence: “recAgfp was freshly transduced into the WT genome by P1 phage transduction to obtain the BW25113::recA-gfp strain (45).” Please, could you indicate the precise integration site in the bacterial chromosome?

It is necessary to include a Statistical Analysis section in the Methods section where the analyzes carried out are specified.

Minor points

Abstract: BMC should be used always after its definition

Abstract: “PAS” is not defined in any part of the text.

Introduction:

L4: References (1-4) does not include information about “some researchers have negated the role of ROS…”

L6: BMC is mentioned at the fort time in the test, please define.

L8: Please change “gram-negative” to “Gram-negative”

Results:

L2: Please change “Effect of BCM” to “effect of BCM”

Figure 1C: Please, change Soxs to SoxS

Please change “TheBCM is known to cause the cell filamentation” to “The BCM is known to cause the cell filamentation”.

Please change “upregulated many-fold in microarray after BCM treatment” to “upregulated up to XX-fold in microarray after BCM treatment”.

Please change “in WT E. coli (Figure 5.B).. BCM” to “in WT E. coli (Figure 5.B). BCM”.

Discussion

Please change “ampicillin, Norfloxacin, and vancomycin” to “ampicillin, norfloxacin, and vancomycin”.

Please change “and H2DCFDA dye in Escherichia coli cells” to “and H2DCFDA dye in E. coli cells”.

Please change “deciphered. Quinones, aminoglycosides” to “deciphered. Quinolones, aminoglycosides”.

In the sentence: “MFI values obtained from three experiments”. MFI is not defined in any place.

In the sentence: “Forte Western HRP substrate (Millipore) was used to develop the”. Correct the end of the sentence.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: José Manuel Rodríguez-Martínez

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Mar 29;19(3):e0293858. doi: 10.1371/journal.pone.0293858.r002

Author response to Decision Letter 0


22 Jan 2024

We thank the Editor and reviewers for the constructive criticism. Below please find point by point responses to yours and their concerns.

Editor’s comments

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

● The name of the colleague or the details of the professional service that edited your manuscript

� The co-author of this manuscript Dr. Dipak Dutta edited this manuscript.

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"This work received funding from intramural grants of CSIR-IMTECH (OLP-0190) and extramural grant to DD from SERB (CRG/2019/001174), Dept. of Science and Technology (DST)."

� The funding related text has been now removed from the manuscript. I want to update the funding statement as “The authors didn’t get any specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

� I request to remove the direct billing option.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Reviewer #1: Methods

- The “Statistical data analysis” section is missing.

� Statistical data analysis is now presented.

Results

- Figure 1.A shows the effect of BCM on the growth of E. coli by measuring OD600 at concentrations of 25 and 50 µg/ml. This indicator reflects the bacteriostatic effect of BCM. However, in this study, the bactericidal effect of antibiotic is more important. It is therefore desirable, in this and other cases, to additionally measure the effect of BCM on the colony forming ability (CFU) of E. coli at concentrations of 25, 50 and 100 µg/ml.

� Previously CFU assays, it has been found that BCM shows very little bactericidal effect if any, even in the very high concentrations range of 200 and 400 µg/ml (Malik et al 2014). Considering the economical aspect of highly priced BCM, instead of repeating the previously done experiments, we consider that reduced growth of bacteria after BCM treatment in our growth curve experiment is in agreement with the finding of the previous study, where it was shown that BCM exerts only bacteriostatic effect.

- Figure 1.A shows the effects of 25 and 50 µg/ml BCM, Figure 1.B shows the effects of 50 and 100 µg/m, and Figure 1.C does not show BCM concentrations at all.

� Concentration of BCM is now shown in Figure 1.C.

- In Supplementary (table 1-3), fluorescence values in the control (without antibiotic) should be indicated.

� The table shows fold change in the values of fluorescence after antibiotic treatment. The fold change was generated by dividing the florescence value got after antibiotic treatment with the fluorescence values without antibiotic treatment.

- In experiments with the addition of antioxidants, it should be taken into account that in the concentrations used can significantly inhibit the growth of bacteria. As is known, even a slight decrease in growth can increase the resistance of bacteria to the action of bactericidal antibiotics. As a result, separate experiments must be performed to determine the effect of antioxidants on both promoter expression and the growth and survival of bacteria treated with antioxidants alone.

� Thanks for suggestion. Growth curve experiments have been now performed in the presence of antioxidants alone and put in supplementary as supplementary Figure 1 B. Addition of tiron has no effect on the growth of WT, growth was exactly same as without tiron. While growth in presence of thiourea mimicked same growth profile with very negligible shift. If we consider this shift responsible for increased resistance of the bacteria to the action of antibiotic then this can’t explain the increase in the resistance to the antibiotic after addition of tiron, as growth profile of the WT after addition of tiron just superimposed on the growth profile without addition of tiron.

Figure 1.B. Checking effect of ROS scavengers, tiron and thiourea on the growth of WT BW25113. WT cells grew almost identically without and with supplementation of thiourea. When tiron was added to the media, WT cells showed very little, if any, slow growth.

- The authors write:

“…Here, we report that apart from the inhibition of Rho function, free radical generation is an important means of BCM toxicity…

…Overall, previous findings and our results suggest that BCM toxicity results from Rho inhibition as well as the generation of free radicals..”.

The authors established the generation of reactive oxygen species by BCM by several methods, but the question of whether these ROS concentrations can have a toxic effect remains open. The toxic effects of bactericidal antibiotics include effects such as reduced survival and lysis, whereas the authors showed only a bacteriostatic effect. The production of ROS in itself does not necessarily lead to a bactericidal effect. Bacteria have powerful antioxidant defenses to prevent the toxic effects of sufficiently high concentrations of ROS.

The study revealed a number of effects associated with the action of BCM, but in order to establish their connection with ROS, additional experiments are required, in particular using mutants in antioxidant systems.

� Thanks for suggestions. We have now checked the effect of BCM on the growth of ΔsodAΔKatGΔahpC triple mutant. Without addition of BCM the triple mutant showed growth identical to the WT, but after addition of BCM the triple mutant displayed reduced growth in comparison to WT (Supplementary Figure 1A).

Figure 1 : A. ΔsodA ΔkatG ΔahpC triple mutant (Δ3) is more sensitive to BCM. WT and Δ3 strains displayed almost identical growth profiles in the absence of BCM. However, Δ3 strain showed more reduced growth in the presence of BCM compared to WT.

Reviewer #2: Dear Editor,

This is an interesting work that deepens and provides new information on the molecular and mechanistic bases in relation to the antimicrobial activity of bicyclomycin. In this work, various experimental approaches are carried out that provide new information of interest. Knowledge of the metabolic response to antimicrobials beyond their interaction with their primary target is a current topic that will be useful for the design of new therapeutic strategies.

Below are various points and comments that I understand are necessary for a better presentation of this work.

Major points

It is necessary to clarify or justify the concentrations of BMC used. Although it is mentioned that concentrations of 25 and 50 μg/ml of BCM were used, it is important to indicate them in relation to the minimum inhibitory concentration (MIC) of this drug. I suspect that it is equivalent to 1/2x and 1x MIC but the CMI value should be specified clearly.

� We agree that the concentration of BCM should have been used in respect to the MIC. Inspired by a study (Cardinale et al 2008), for which they used 10 μg/ml, 25 μg/ml and 100 μg/ml of BCM, we were more absorbed in deciphering the role of Rho in various cellular metabolism like heat shock response, manganese toxicity (Prakash et al. Biorxiv 2023). However, the MIC of BCM for WT BW25113 is 37µg/ml (Malik et al. 2014), which lies approximately in the middle of 25 μg/ml and 50 μg/ml concentrations used in our study. This forms a good rationale for the concentrations used in present study. We have now justified the our chosen BCM concentrations in the manuscript in L4 of Results section.

Results (L5): I disagree with this sentence: “We suspected that the reduced growth may be due to increased ROS levels in the cells after BCM treatment.” The main molecular mechanism of growth inhibition by BMC is already known (Rho inhibition). Please rewrite this sentence.

� The sentence has been now modified.

I have important doubts with the quality of the images provided, at least in the version that I have been able to view. Please improve the quality of the images, especially Figure 1D, 4D, 5A and 4C. Additionally, I think that Figure 1F could be incorporated into Figure 2.

� We have rechecked the image quality, all the uploaded images are of 300 dpi resolution. The images in manuscript draft that I downloaded also not looked as good quality that I submitted to the portal. In the figure 4.D the colocalization foci of DAPI and GFP has been now more precisely indicated.

An important aspect of the work is that it should be more clearly specified what type of reactive oxygen species are detected by the DHE and H2DCFDA probes. This should be described precisely in Methods. In relation to this, the Results statement "These results suggest that exposure to BCM also leads to the generation of highly deleterious hydroxyl radicals" is not clear. Why do we talk about "hydroxyl radicals" specifically if H2DCFDA is a generic ROS marker?

� The ROS species detected by the two dyes are now described in the Materials and Methods. Thiourea is a ROS scavenger that is specific for hydroxyl radicals. So, when increased fluorescence of H2DCFDA after addition of BCM is quenched by supplementation of thiourea, it is safe to reason that BCM treatment leads to the generation of hydrioxyl radicals.

Please delete this sentence from Discussion; “Although, we did not check the envelope stress after BCM treatment, it may be implicated in the generation of ROS after BCM treatment.” It is excessively speculative.

� Earlier, it has been reported that misfolded proteins leads to ROS production in the cells through envelop stress response pathway (Kohanaski et al. 2008). Rho inhibition also results in unregulated protein expression. So, it seems reasonable to anticipate that Rho inhibition can potentially cause envelope stress.

Methods: In relation to this sentence: “recAgfp was freshly transduced into the WT genome by P1 phage transduction to obtain the BW25113::recA-gfp strain (45).” Please, could you indicate the precise integration site in the bacterial chromosome?

� When I looked at the reference article where construction of recA-gfp described, it turned out that the gfp coding sequence has been fused to recA promoter. So, when a P1 phage is transduced in BW25113, by homologous recombination the recA:gfp construct will recombine at the recA promoter in the bacterial chromosome.

It is necessary to include a Statistical Analysis section in the Methods section where the analyzes carried out are specified.

� Statistical analyses is now presented in the Materials and Methods section

Minor points

Abstract: BMC should be used always after its definition

� BCM is defined now in the Abstract as well as in L-6 in the Introduction text.

Abstract: “PAS” is not defined in any part of the text.

� PAS is now defined in the Abstract section as well in L-5 of Discussion section.

Introduction:

L4: References (1-4) does not include information about “some researchers have negated the role of ROS…”

� Information in the citations now has been included.

L6: BMC is mentioned at the fort time in the test, please define.

� BCM is now defined there.

L8: Please change “gram-negative” to “Gram-negative”

� “gram-negative” is now changed to “Gram-negative”

Results:

L2: Please change “Effect of BCM” to “effect of BCM”

� It has been changed.

Figure 1C: Please, change Soxs to SoxS

� It has been changed.

Please change “TheBCM is known to cause the cell filamentation” to “The BCM is known to cause the cell filamentation”.

� Iit has been changed.

Please change “upregulated many-fold in microarray after BCM treatment” to “upregulated up to XX-fold in microarray after BCM treatment”.

� It has been changed.

Please change “in WT E. coli (Figure 5.B).. BCM” to “in WT E. coli (Figure 5.B). BCM”.

� It has been changed.

Discussion

Please change “ampicillin, Norfloxacin, and vancomycin” to “ampicillin, norfloxacin, and vancomycin”.

� It has been changed.

Please change “and H2DCFDA dye in Escherichia coli cells” to “and H2DCFDA dye in E. coli cells”.

� It has been changed.

Please change “deciphered. Quinones, aminoglycosides” to “deciphered. Quinolones, aminoglycosides”.

� It has been changed.

In the sentence: “MFI values obtained from three experiments”. MFI is not defined in any place.

� Now, MFI has been defined under “Checking ROS level and induction of SOS response by flow cytometry” heading in the “Materials and Methods section”, where it appearead first.

In the sentence: “Forte Western HRP substrate (Millipore) was used to develop the”. Correct the end of the sentence.

� It has been now corrected.

References

1.Cardinale CJ, Washburn RS, Tadigotla VR, Brown LM, Gottesman ME, Nudler E. Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E-coli. Science. 2008;320(5878):935-8.

2.Malik M, Li L, Zhao X, Kerns RJ, Berger JM, Drlica K. Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics. J Antimicrob Chemother. 2014;69(12):3227-35.

3.Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death. Cell. 2008;135(4):679-90.

4.Prakash A, Kalita A, Kanika B, …Dutta D. Rho and a riboswitch regulate mntP expression evading manganese stress and membrane toxicity. Biorxiv. 2023

Attachment

Submitted filename: Response to reviewers.docx

pone.0293858.s003.docx (142.1KB, docx)

Decision Letter 1

Samiullah Khan

27 Feb 2024

Bicyclomycin generates ROS and blocks cell division in Escherichia coli

PONE-D-23-34381R1

Dear Dr. Prakash,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Samiullah Khan, Ph. D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear author,

The manuscript has been revised appropriately, both reviewrs are satisfied with the revised version. I recommend the manscript is now acceptable for publication in PLoS ONE.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors' main objective was to test whether the induction of oxidative stress could explain the increased sensitivity of Escherichia coli to bicyclomycin. It was shown that BCM indeed caused the formation of ROS, inducing cell filamentation as part of the SOS response. The results of the work allow us to develop more effective approaches to the use of BCM in clinical practice. The authors generally took into account my comments, however, considering the methods and approaches they used in this work, the question of the role of ROS in the action antibiotics remains controversial. According to the reviewer, in the future it is necessary to accumulate additional and more convincing evidence to solve the problem. The foregoing does not diminish the merits of the work under review.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: José Manuel Rodríguez Martínez

**********

Acceptance letter

Samiullah Khan

21 Mar 2024

PONE-D-23-34381R1

PLOS ONE

Dear Dr. Prakash,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Samiullah Khan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    pone.0293858.s001.docx (192.4KB, docx)
    S2 File

    (XLSX)

    pone.0293858.s002.xlsx (13.6MB, xlsx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0293858.s003.docx (142.1KB, docx)

    Data Availability Statement

    All relevent data are within the manuscript and its supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES